Immunogenomics of Disease: Accelerating to Patient Benefit06 - 08 February 2017Wellcome Genome Campus, Hinxton, UK
Deadlines (at 23:59 UTC):
- Bursary Deadline Closed
- Abstract Deadline Closed
- Registration Deadline Closed
This new conference aims to bring together scientists working in the fields of molecular immunology, functional genomics and immune-mediated disease genetics, to expedite the journey from genetic association to mechanistic understanding and patient benefit through new insights into disease and novel therapeutics.
Next generation sequencing has accelerated the discovery of highly
penetrant causal variants in diverse primary immune deficiencies,
providing insight into the non-redundant functions of the affected genes
and pathways in human immunity. In parallel, the application of GWAS has
been arguably most successful in immune-related traits, such that
together we now have evidence of the role of genetic variation in
susceptibility to various immune diseases across the prevalence spectrum.
To accelerate the translation of these discoveries into the clinic, we
urgently need to improve our understanding of the molecular consequences
of disease-associated variants, immunological processes and drug target
This meeting will focus on recent successful stories in immune-mediated disease gene-mapping, causal variant identification in common and rare immune diseases, and efforts to understand the cellular consequences of these variants on the innate and adaptive immune system. We will highlight technological developments that promise to deliver further insight into the biology of the immune system in both health and disease, such as single cell sequencing, metagenomic sequencing and genome editing.
The conference will start at approximately 12.30 on Monday 6 February and
close at approximately 13.30 on Wednesday 8 February 2017.
Topics will include:
- Autoimmunity and autoinflammation
- Primary immune deficiencies
- Immunology and the microbiome
- Genomic diversity of immune cells
- Immune regulation and homeostasis
- Therapeutic advances
Please click here for a copy of the programme.
- Organisers / Speakers
Ivona Aksentijevich National Institutes of
Mary Carrington National Cancer Institute
Center for Cancer Research, USA
Yanick Crow Imagine Institute, France
Lars Fugger University of Oxford, UK
Michel Georges University of Liege,
Claire Harris Newcastle University, UK
Eric Meffre Yale University, USA
Anjana Rao La Jolla Institute for Allergy
& Immunology, USA
Soumya Raychaudhuri Harvard Medical School, USA
Kathy (Moser) Sivils Oklahoma Medical
Research Foundation, USA
Gregory Sonnenberg Weill Cornell Medicine,
Sarah Teichmann Wellcome Trust Sanger Institute, UK
Gosia Trynka Wellcome Trust Sanger
Holm Uhlig University of Oxford, UK
Cisca Wijmenga University of Groningen, The Netherlands
Jemma Beard Wellcome Genome Campus, UK
- Registration / Accommodation
Student No accommodation £281 Student On site twin accommodation £383 Student On site single accommodation £445 Academic No accommodation £381 Academic On site twin accommodation £483 Academic On site single accommodation £545 Commercial No accommodation £481 Commercial On site twin accommodation £583 Commercial On site single accommodation £645
The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
Registration deadline: Closed
Accommodation is provided for the nights of 6 and 7 February 2017. Please
note: there is limited onsite accommodation and this will be allocated on
a first-come, first-served basis. Therefore, early registration is
If you wish to book onsite accommodation either side of the conference
dates, please contact the Conference Centre directly.
Contact the conference organiser if you require a letter to support a
travel visa application. Please note: letters will only be provided to
Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
Please visit the following websites for further information:
UK Border Agency website: www.ukba.homeoffice.gov.uk/visas-immigration/
Information for general visitors and business visitors: www.ukba.homeoffice.gov.uk/visas-immigration/visiting/business/business-activities/
We welcome abstracts from all areas relevant to the main themes of the
meeting, for both oral and poster presentations. Several oral
presentations will be chosen from the abstracts submitted.
Abstracts will only be considered from registered delegates. Please use our online abstract submission system and follow the instructions given to ensure your abstract is submitted correctly. All abstracts must be submitted by the deadline. If you are intending to submit more than one abstract, please contact the conference organiser prior to registration.
The scientific programme committee will assess your abstract after the
deadline has passed and you will be notified whether you have been
selected for an oral or poster presentation.
Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-
portrait) of printed material. Accepted abstracts will appear in the
conference programme book and poster boards will be allocated at the
Abstract deadline: Closed
Abstract guidelines can be viewed here.
A limited number of registration bursaries are available for PhD students
to attend this conference (up to 50% of the registration fee) from
Wellcome Genome Campus Scientific Conferences.
The following documents will need to be provided:
- Covering letter
- Letter from supervisor
To apply, please contact the conference organiser.
Bursary deadline: 22 November 2016